Appointments: New Leadership At ABPI, CMOs Appointed At Acceleron and Biophytis
Pfizer's Erik Nordkamp has been named as the new president of the Association of the British Pharmaceutical Industry. Vant, Grail, Acceleron, Kite, Nimbus, Biophytis, Orchard Therapeutics, G1 Therapeutics, Almac Discovery, Athenex and Sunesis have also made key appointments.
You may also be interested in...
The Danish biotech is looking to end 2022 on a high after raising over $105m and posting positive Phase III data on glepaglutide.
The Swedish biotech is well positioned with soon-to-be late-stage clinical assets, commercial validation and a strong pipeline, new CEO Richard Godfrey tells Scrip.
Having led $30bn of acquisitions of companies at Sanofi, the new challenge for its former global head of partnering is to help make Owkin, “the most disruptive AI biotech company in the world,” he tells Scrip.